Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Symbicort (budesonide/formoterol) and Advair (fluticasone/salmeterol) are both combination inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD). They belong to the same medication class, combining an inhaled corticosteroid (ICS) with a long-acting beta-agonist (LABA). However, there are some differences between the two. Symbicort is available in two strengths and is typically taken as two inhalations twice a day, while Advair comes in different strengths and is usually taken as one or two inhalations twice a day, depending on the formulation. Symbicort is available in generic form, while Advair has a generic version called Wixela Inhub. Both medications can cause an oral fungal infection called thrush. You can reduce your risk for thrush by rinsing your mouth out with water and spitting it out after each use.
Symbicort (budesonide / formoterol)
Advair (fluticasone / salmeterol)
Symbicort (budesonide / formoterol)
Advair (fluticasone / salmeterol)
Summary of Symbicort vs. Advair
Summary for Inhaled corticosteroid / LABA
Prescription only
Symbicort (budesonide / formoterol) is a combination inhaler used to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two medications: budesonide, a steroid, and formoterol, a long-acting beta-agonist (LABA). Both medications work together to reduce inflammation in the lungs and open up your airways. The typical dose is two puffs by mouth twice a day, usually about 12 hours apart. Common side effects include common cold symptoms, headache, and sore throat.